Tag - pharmaceuticals

 
Menu
Search
 
April 10, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
WORLD
Dec 22, 2020
EU clears Pfizer COVID-19 vaccine for first inoculations
Preparations for the vaccine roll-out come as the identification of a highly infectious new strain of the coronavirus in Britain caused chaos across the region.
Japan Times
WORLD / FOCUS
Dec 19, 2020
World looks to spring for pandemic relief as vaccinations start
The developed world could start to emerge from the deadly grip of the pandemic by late spring if the first wave of COVID-19 vaccines are deployed effectively.
JAPAN / Science & Health
Dec 18, 2020
Pfizer first drugmaker to seek COVID-19 vaccine approval in Japan
Officials said the approval would be made 'a top priority in the screening process' once the firm submits data from an ongoing clinical trial specific to Japan, expected in February.
Japan Times
WORLD
Dec 17, 2020
WHO plan risks leaving poor nations with no COVID-19 vaccines until 2024
Documents show the program's promoters say it is struggling from a lack of funds, supply risks and complex contractual arrangements which could make it impossible to achieve its goals.
Japan Times
ASIA PACIFIC / Science & Health
Dec 16, 2020
With goal of herd immunity, Indonesia will give younger people vaccines first
The country is targeting the people who are most mobile due to their jobs, as well as regions with the highest number of coronavirus cases.
Japan Times
WORLD
Dec 15, 2020
A weapon to ‘win the war’: U.S. hospitals get initial coronavirus shots
The arrival of the Pfizer-BioNTech vaccine offers a glimmer of hope amid a pandemic that has already seen almost 300,000 Americans die.
Japan Times
ASIA PACIFIC
Dec 15, 2020
In Asia first, Singapore approves Pfizer's COVID-19 vaccine
Singapore has become the first Asian country to approve the Pfizer-BioNTech coronavirus vaccine and said it expects to start receiving shots by the end of the year.
Japan Times
BUSINESS
Dec 11, 2020
Why Japan is largely a spectator in the coronavirus vaccine race
A total of 52 vaccine candidates were in clinical evaluation worldwide as of Tuesday, of which only one was Japanese.
Japan Times
WORLD
Dec 10, 2020
U.S. nears final COVID-19 vaccine review as daily deaths top 3,250
Steady movement toward a vaccine rollout on the eve of a critical review by leading U.S. medical experts comes as COVID-19 caseloads surged alarmingly higher, straining health care systems.
Japan Times
WORLD / Science & Health
Dec 10, 2020
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
Japan Times
WORLD / Science & Health
Dec 9, 2020
China’s state-backed coronavirus vaccine has 86% efficacy, says UAE
China’s state-backed coronavirus vaccine protected 86% of people from getting COVID-19 in trials conducted in the United Arab Emirates, reported media outlets including Reuters, citing the UAE’s health ministry.
Japan Times
WORLD / Science & Health
Dec 9, 2020
Testing times: More work needed on AstraZeneca/Oxford vaccine trials
A Lancet study gave few extra clues about why efficacy was 62% for trial participants given two full doses, but 90% for a smaller subgroup given a half, then a full dose.
Japan Times
WORLD / Science & Health
Nov 29, 2020
COVID-19 drugs from Lilly and Regeneron raise access and timing concerns
Powerful drugs recently authorized by the U.S. that may prevent those at the earliest stages of COVID-19 from suffering severe disease present thorny new challenges, including who will get them and where they’ll be administered.
Japan Times
WORLD / Science & Health
Nov 26, 2020
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Japan Times
WORLD / Science & Health / FOCUS
Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
Japan Times
WORLD / Science & Health
Nov 21, 2020
Two companies say their vaccines are 95% effective. What does that mean?
You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that's not how the math works.
Japan Times
WORLD / Science & Health
Nov 20, 2020
WHO advises doctors not to use Gilead’s remdesivir for COVID-19
The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients.
Wall Street will regret helping the world burn
Wall Street banks, under political pressure and tempted by short-term gains, are abandoning climate commitments and pouring billions into fossil fuels, risking both environmental catastrophe and massive future economic losses.
Trump's tariff gambit leaves Asia stunned and scrambling
U.S. President Donald Trump speaks as he attends the National Republican Congressional Committee dinner in Washington on Tuesday. Trump allowed new tariffs — including a 24% levy on Japan — to go into effect as scheduled on Wednesday.
Japan and U.S. appoint tariff negotiators after Ishiba-Trump phone call
Economic revitalization minister Ryosei Akazawa enters the Prime Minister's Office in Tokyo on Tuesday.
Japanese makers rush to mitigate possible Nankai Trough earthquake damage
Toyota is considering transferring some production in the key Tokai region, which is expected to be hit hard in a Nankai Trough earthquake, to the Tohoku and Kyushu regions.
Why Japan is running out of rice — and farmers to grow it
An ongoing shortage of rice has resulted in rising prices for Japan's main food staple.
After a tumultuous buildup, a first look at the Osaka Expo
A large statue of Osaka Expo mascot Myaku Myaku sits near the east entrance of the event's venue in Yumeshima island, Osaka, on Wednesday.
Japan gets a new U.S. ambassador — and he has his work cut out for him
George Glass, U.S. President Donald Trump's pick to be ambassador to Japan, attends a Senate Foreign Relations Committee confirmation hearing in Washington on March 13.
Online art scene eager to go offline, at least for the moment
Digital artist Polygon1993 revels in the physicality of nostalgic technology, making art out of materials such as miniature CDs, holographic prints layered with plexiglass shards and a giant custom-made floppy disk.
Tottori takes a bold leap forward in the arts
The city of Kurayoshi in Tottori Prefecture celebrated the opening of its public art museum with festivities such as a parade that drew 1,000 revelers.
Haruki Murakami TV adaptation revisits 30 years of watershed moments
Though Haruki Murakami's trademark whiff of offbeat existentialism is threaded throughout NHK's "After the Quake," the final episode — conceived as a sequel to the story "Super-Frog Saves Tokyo" — is the most stylized, featuring an anthropomorphic talking frog (voiced by Non) and his erstwhile associate Katagiri (Koichi Sato).

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

An ongoing shortage of rice has resulted in rising prices for Japan's main food staple.
Why Japan is running out of rice — and farmers to grow it
By Alex K.T. Martin

SUSTAINABLE JAPAN

BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)
BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER